Biocon

Corporate Shifts and Regulatory Hurdles Impacting Major Market Players

Mutual fund investments increase across large, mid, and small-cap segments.

Financial experts discuss market insights in a high-rise office in an Indian metropolis.

Patient holds a Yesintek (ustekinumab-kfce) single-dose prefilled autoinjector.

Adult patient holding a Yesintek single-dose prefilled autoinjector in a home setting.

Infographic: Mutual Funds Boost Biocon, PB Fintech Amid Mid-Cap Inflows in July

A silver high-speed train travels on multiple tracks under a clear sky.

Infographic: HDFC, Parag Parikh Flexi Cap Funds Adjust Portfolios in July 2026

Financial analyst reviews stock market data on multiple screens in a modern office.

Infographic: Biocon Shares Jump Nearly 3% as Q1 Profit Surges 348.4%

Infographic: Power Grid, Cummins, Aurobindo Pharma Q1 Earnings Estimates Set for August 5

Infographic: Rail Vikas Nigam Surges, Biocon Gains Health Canada Nod as Indian Equities Rise

Researcher in an Indian biotechnology lab examines a sample, indicating a drug discovery breakthrough.

Infographic: US Tariffs Threaten Indian Pharma’s Dominance in Generic Drugs

Indian factory workers assemble electronic components on a production line.

Indian financial market professionals monitor data at the India Bullion & Securities Exchange.

Corporate building in Indian financial district under regulatory observation.

Biocon Partner Lands Big Malaysia Insulin Deal; ABB India Powers Kolkata Metro

Infographic: Startup Ecosystem Buzz: Key Updates from India’s Business Landscape

Claire Mazumdar and Kiran Mazumdar-Shaw collaborating in a Biocon laboratory.

Biocon executive speaks at a U.S. launch event for new biosimilar drugs.